Patents · inventor
Dmitry Samarsky
- Patents
- 30 granted 2014-03-04 to 2026-04-28
- Places
- Berlin, DE; Gaithersburg, MD; Westborough, MA
- Most often assigned to
- RXi Pharmaceuticals Corporation
- Source
- PVGPATDIS, file of 2026-04-28; PatentsView inventor ID fl:dm_ln:samarsky-1
Patents
| Patent | Title | Granted | Assignees | Source |
|---|---|---|---|---|
| US 12612626 | siRNA compound that inhibits expression of APOC3 | 2026-04-28 | SIRNAOMICS, INC. | PTBLXML, file of 2026-04-28 |
| US 12600967 | SiRNA compound that inhibits complement factor B (CFB) | 2026-04-14 | SIRNAOMICS, INC. | PTBLXML, file of 2026-04-14 |
| US 12378552 | Oligomeric compound for inhibiting expression of factor XI | 2025-08-05 | Sirnaomics, Inc. | PVGPATDIS, file of 2026-04-10 |
| US 12084656 | Products and compositions | 2024-09-10 | Sapience Therapeutics, Inc. | PVGPATDIS, file of 2026-04-10 |
| US 11987794 | Products and compositions | 2024-05-21 | Sapience Therapeutics, Inc. | PVGPATDIS, file of 2026-04-10 |
| US 11584933 | RNA interference in ocular indications | 2023-02-21 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 11414660 | Products and compositions | 2022-08-16 | Sapience Therapeutics, Inc. | PVGPATDIS, file of 2026-04-10 |
| US 11396654 | Neutral nanotransporters | 2022-07-26 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 11299738 | Further novel oligonucleotide-ligand conjugates | 2022-04-12 | Sapience Therapeutics, Inc. | PVGPATDIS, file of 2026-04-10 |
| US 11118178 | Reduced size self-delivering RNAI compounds | 2021-09-14 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 11015198 | Products and compositions | 2021-05-25 | Sapience Therapeutics, Inc. | PVGPATDIS, file of 2026-04-10 |
| US 10913948 | RNA interference in dermal and fibrotic indications | 2021-02-09 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10876119 | Reduced size self-delivering RNAI compounds | 2020-12-29 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10815485 | RNA interference in skin indications | 2020-10-27 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10774330 | Reduced size self-delivering RNAI compounds | 2020-09-15 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10662430 | RNA interference in ocular indications | 2020-05-26 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10240149 | Reduced size self-delivering RNAi compounds | 2019-03-26 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10184124 | RNA interference in ocular indications | 2019-01-22 | Phio Pharmaceuticals Corp. | PVGPATDIS, file of 2026-04-10 |
| US 10138485 | Neutral nanotransporters | 2018-11-27 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 10041073 | Reduced size self-delivering RNAi compounds | 2018-08-07 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9963702 | RNA interference in dermal and fibrotic indications | 2018-05-08 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9938530 | RNA interference in skin indications | 2018-04-10 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9340786 | RNA interference in dermal and fibrotic indications | 2016-05-17 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9303259 | RNA interference in skin indications | 2016-04-05 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9175289 | Reduced size self-delivering RNAi compounds | 2015-11-03 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9095504 | RNA interference in ocular indications | 2015-08-04 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 9080171 | Reduced size self-delivering RNAi compounds | 2015-07-14 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 8815818 | Phagocytic cell delivery of RNAI | 2014-08-26 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 8796443 | Reduced size self-delivering RNAi compounds | 2014-08-05 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
| US 8664189 | RNA interference in skin indications | 2014-03-04 | RXi Pharmaceuticals Corporation | PVGPATDIS, file of 2026-04-10 |
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. PatentsView groups an inventor’s patents by name, place and co-inventors (disambiguation); a person page link is by name and state, or name and employer.